Novartis AG Deferred Tax Assets
Novartis AG (NVSEF) had Deferred Tax Assets of $5.44 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes › Income Taxes
ifrs-full:DeferredTaxAssets · last filed 2026-02-04
- 2025-12-31: Deferred Tax Assets $5.44B.
- 2025-06-30: Deferred Tax Assets $5.20B.
- 2024-12-31: Deferred Tax Assets $4.36B.
- 2024-06-30: Deferred Tax Assets $4.40B.
| Period end | Deferred Tax Assets | Deferred Tax Assets as first filed |
|---|---|---|
| 2025-12-31 | $5.44B 20-F · filed 2026-02-04 | |
| 2025-06-30 | $5.20B 6-K · filed 2025-07-17 | |
| 2024-12-31 | $4.36B 20-F · filed 2026-02-04 | |
| 2024-06-30 | $4.40B 6-K · filed 2024-07-18 | |
| 2023-12-31 | $4.31B 20-F · filed 2025-01-31 | |
| 2023-06-30 | $4.04B 6-K · filed 2023-07-18 | |
| 2022-12-31 | $3.74B 20-F · filed 2024-01-31 | |
| 2022-06-30 | $3.62B 6-K · filed 2022-07-19 | |
| 2021-12-31 | $3.74B 20-F/A · filed 2023-05-15 | |
| 2021-06-30 | $8.05B 6-K · filed 2021-07-21 | |
| 2020-12-31 | $3.93B 20-F · filed 2022-02-02 | $8.21B 20-F · filed 2021-01-26 |
| 2020-06-30 | $8.60B 6-K · filed 2020-07-21 | |
| 2019-12-31 | $7.91B 20-F · filed 2021-01-26 | |
| 2019-06-30 | $7.83B 6-K · filed 2019-07-18 | |
| 2018-12-31 | $8.70B 20-F · filed 2020-01-29 | |
| 2018-06-30 | $8.22B 6-K · filed 2018-07-18 | |
| 2018-01-01 | $8.22B 20-F · filed 2019-01-30 | |
| 2017-12-31 | $8.23B 20-F · filed 2019-01-30 | |
| 2016-12-31 | $10.03B 6-K · filed 2018-01-24 |